Mary Tipton, MD
Pediatrics · West Jordan, UTNPI 1922065598
Payments from drug & device makers
Across 697 payments — averaging $4079.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$1.1M
- Merck$832K
- Pfizer$455K
- Sanofi Pasteur Inc.$313K
- AstraZeneca$104K
- Astrazeneca UK Limited$29K
- plus $2K from 32 others
Across 8 payments — averaging $1160.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$9K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 313 | $1,108,208 |
| Merck | 39 | $831,962 |
| Pfizer | 114 | $454,874 |
| Sanofi Pasteur Inc. | 46 | $312,640 |
| AstraZeneca | 33 | $103,692 |
| Astrazeneca UK Limited | 6 | $29,283 |
| AbbVie(2 entities) | 22 | $471 |
| Lilly USA, LLC | 23 | $364 |
| Abbott | 10 | $259 |
| Novo Nordisk | 23 | $245 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $122 |
| Boehringer Ingelheim | 7 | $116 |
| Sunovion Pharmaceuticals Inc. | 6 | $87 |
| Biohaven Pharmaceuticals, Inc. | 4 | $83 |
| Vistapharm, Inc. | 4 | $76 |
| Boston Scientific | 3 | $67 |
| Sobi, Inc | 2 | $63 |
| Sanofi-aventis U.S. LLC | 4 | $55 |
| Johnson & Johnson | 3 | $52 |
| Cranial Technologies, Inc | 3 | $45 |
| Supernus Pharmaceuticals, Inc. | 3 | $44 |
| Ironshore Pharmaceuticals Inc. | 3 | $38 |
| Mannkind Corporation | 2 | $36 |
| Teva Pharmaceuticals USA, Inc. | 2 | $25 |
| Eisai Inc. | 1 | $23 |
| Therapeuticsmd, Inc. | 1 | $21 |
| Genentech USA, Inc. | 1 | $19 |
| Corium, LLC | 1 | $19 |
| Hologic Sales And Service, LLC | 1 | $18 |
| Alkermes, Inc. | 1 | $17 |
| Amgen | 1 | $15 |
| Apria Healthcare LLC | 1 | $15 |
| Azurity Pharmaceuticals, Inc. | 1 | $15 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $14 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| Shire North American Group Inc | 1 | $14 |
| Dexcom, Inc. | 1 | $12 |
| Amarin Pharma, Inc. | 1 | $11 |
How this compares
$2,843,136 in reported general payments places this provider in the 95th percentile of 439 pediatrics providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pediatrics in West Jordan
- Adam HutchinsonWest Jordan$140K
- John DavisWest Jordan$61K
- Peter SilasSyracuse$4M
- Nathan ForbushLayton$3.6M
- Michael HussemanLayton$2.9M
- Jake JonesMurray$2.6M
- Robert HokiLayton$1.4M
- Laurent SiggLayton$1.2M
- Joshua FullerProvo$1.2M
- Daniel NeumannRoy$953K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.